| Form of release | Blister (25 tablets), Pack (100 tablets) |
|---|---|
| International Name | Testolone (RAD-140) |
| Chemical Name | 2-Chloro-4-{[(1R,2S)-1-(5-hydroxy-1,3,4-oxadiazol-2-yl)-2-hydroxypropyl]amino}-3-methylbenzonitrile |
| Type of Drug Combination | SARM (selective androgen receptor modulator) |
| Molecular Formula | C20H16ClN5O2 |
| Molecular Weight | 393.83 g/mol |
| Halflife | 16–20 hours |
| Mechanism of Action | Selectively binds to androgen receptors in muscle and bone tissue, stimulating protein synthesis and anabolic processes. |
| Anabolic Activity | Very high |
| Androgenic Activity | Low |
| Main Effects | Increased muscle mass, strength, endurance; accelerated recovery; reduced fat tissue |
| Side Effects | Suppression of testosterone production, irritability, insomnia, headaches, possible increase in liver enzymes |
| thenecessityofpct | Required |
| Recommended Dosage | 10–30 mg per day |
| Course Duration | 6–10 weeks |
| Reception Hours | Once a day (preferably in the morning or 30–60 minutes before training) |
| Impact on Estrogens | No |
| Impact on the Liver | Moderate |
| Storage | In a dry, cool place, protected from light, at a temperature not exceeding 25°C |
| Use by Women | Acceptable in small doses (5–10 mg), but with a risk of virilization |
| Detection Period in the body | Up to 3 weeks |
